Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Months after acquiring Warp Drive Bio, Revolution Medicines has sold the biotech firm’s genome-mining platform to Ginkgo Bioworks, a Boston-based synthetic-biology firm. Warp Drive has amassed sequencing data for more than 135,000 bacterial strains, a library that researchers sift through in search of clusters that encode for specific structural elements of compounds. Ginkgo says it will continue work related to a 2017 antibiotics drug-discovery pact established between Roche and Warp Drive.
This article has been sent to the following recipient: